Swedish Orphan Biovitrum (Sobi) has agreed a merger with CTI BioPharma, a US biopharmaceutical company focused on blood-related cancers and rare diseases. Through a...
27.05.2016
- Janssen-Cilag, a subsidiary of US healthcare giant Johnson & Johnson, has been granted conditional approval in Europe for Darzalex (daratumumab) to treat patients with relapsed and...
24.03.2011
- Scientists have mapped out the full genetic code of 38 people with multiple myeloma, uncovering never-before suspected genes that play a role in the blood cancer and showing that a...
